Integral Diagnostics Ltd (ASX:IDX)
A$ 2.92 0.05 (1.74%) Market Cap: 1.07 Bil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 2.22 GF Score: 85/100

Half Year 2024 Integral Diagnostics Ltd Earnings Call Transcript

Feb 19, 2024 / 11:00PM GMT
Release Date Price: A$2.09 (-0.48%)
Operator

Thank you for standing by, and welcome to the Integral Diagnostics Fiscal Year '24 IDX Half Year Results Call. (Operator Instructions)

I would now like to hand the conference over to Dr. Ian Kadish, CEO. Please go ahead.

Ian Kadish
Integral Diagnostics Ltd - Chief Executive Officer, Managing Director, Executive Director

Thank you very much. My name is Ian Kadish. I'm the Chief Executive Officer and Managing Director of Integral Diagnostics. I'm joined here this morning by Craig White, the Chief Financial Officer of Integral Diagnostics. And we're pleased this morning to be able to share IDX's first half financial year '24 financial results with you.

At IDX, our vision is to build a healthier world and we do this by delivering the best health outcome for every patient we serve. We always put our patients first, we demonstrate medical leadership. We ensure that everyone counts. We create value and we embrace change.

We delivered on our values in the first half of '24 by serving 600,000 patients in the first half. We performed more

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot